Lu W - Search Results

1

A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.

Li B, Zhang L, Zhang Z, Yan G, Zhu L, Lu W, Yu H. Li B, et al. Among authors: lu w. Eur J Gastroenterol Hepatol. 2019 Feb;31(2):218-223. doi: 10.1097/MEG.0000000000001281. Eur J Gastroenterol Hepatol. 2019. PMID: 30277926

2

Quantitative Anti-HBc in Liver Pathological States in Patients with Chronic Hepatitis B Virus Infection.

Zhang ZQ, Shi BS, Lu W, Liu DP, Huang D, Feng YL. Zhang ZQ, et al. Among authors: lu w. Can J Infect Dis Med Microbiol. 2019 Dec 25;2019:6545642. doi: 10.1155/2019/6545642. eCollection 2019. Can J Infect Dis Med Microbiol. 2019. PMID: 31949546 Free PMC article.

3

Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients.

Zhang ZQ, Shi BS, Lu W, Liu DP, Huang D, Feng YL. Zhang ZQ, et al. Among authors: lu w. Gastroenterol Hepatol. 2020 Nov;43(9):526-536. doi: 10.1016/j.gastrohep.2020.03.017. Epub 2020 Sep 10. Gastroenterol Hepatol. 2020. PMID: 32921478 Review. English, Spanish.

4

Comparison of telbivudine efficacy in treatment-naive patients with hepatitis B virus-related compensated and decompensated cirrhosis in 96 weeks.

Yang X, Li J, Zhou L, Liu J, Wang J, Lu W. Yang X, et al. Among authors: lu w. Eur J Gastroenterol Hepatol. 2014 Apr;26(4):396-403. doi: 10.1097/MEG.0000000000000062. Eur J Gastroenterol Hepatol. 2014. PMID: 24569820

5

Clinical relevance of the in situ assay for HBV DNA: a cross-sectional study in patients with chronic hepatitis B.

Liu D, Xu T, Shi B, Lu W, Zheng Y, Feng Y, Yuan Z, Zhang X, Zhang Z. Liu D, et al. Among authors: lu w. J Clin Pathol. 2020 Dec;73(12):813-818. doi: 10.1136/jclinpath-2020-206440. Epub 2020 May 13. J Clin Pathol. 2020. PMID: 32404474 Free PMC article.

6

[Diagnostic value of FibroTest for liver fibrosis in patients with chronic hepatitis B].

Wang C, Cheng X, Meng C, Lu W. Wang C, et al. Among authors: lu w. Zhonghua Gan Zang Bing Za Zhi. 2015 Oct;23(10):738-41. doi: 10.3760/cma.j.issn.1007-3418.2015.10.006. Zhonghua Gan Zang Bing Za Zhi. 2015. PMID: 26573189 Chinese.

7

[Value of controlled attenuation parameter in diagnosis of fatty liver using FibroScan].

Xu L, Li P, Lu W, Shi Q, Shi R, Zhang X, Liu Y, Wang Q, Fan J, Mi Y. Xu L, et al. Among authors: lu w. Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):108-13. doi: 10.3760/cma.j.issn.1007-3418.2016.02.007. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 26983477 Chinese.

8

A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B.

Xu L, Lu W, Li P, Shen F, Mi YQ, Fan JG. Xu L, et al. Among authors: lu w. Dig Liver Dis. 2017 Aug;49(8):910-917. doi: 10.1016/j.dld.2017.03.013. Epub 2017 Mar 30. Dig Liver Dis. 2017. PMID: 28433586

9

Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

Mi YQ, Shi QY, Xu L, Shi RF, Liu YG, Li P, Shen F, Lu W, Fan JG. Mi YQ, et al. Among authors: lu w. Dig Dis Sci. 2015 Jan;60(1):243-51. doi: 10.1007/s10620-014-3341-x. Epub 2014 Sep 7. Dig Dis Sci. 2015. PMID: 25194851

10

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.

Wang J, Li P, Jiang Z, Yang Q, Mi Y, Liu Y, Shi R, Zhou Y, Wang J, Lu W, Li S, Liu D. Wang J, et al. Among authors: lu w. Korean J Intern Med. 2016 May;31(3):479-87. doi: 10.3904/kjim.2015.253. Epub 2016 Mar 30. Korean J Intern Med. 2016. PMID: 27025268 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,724 results

Search Page

Filters